RBF Capital, LLC

SEC CIK: 0001134621
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

TSHA holding history

Taysha Gene Therapies, Inc. in every 13F filed by RBF Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TSHA overview All 13F holders of TSHA Full Q2 2026 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2022

Holdings of TSHA by RBF Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−13,800−100.0%	Sold out	Holders
Q4 2022	13,800	$31.0K	<0.1%	00.0%	Unchanged	Holders
Q3 2022	13,800	$27.0K	<0.1%	00.0%	Unchanged	Holders
Q2 2022	13,800	$51.0K	<0.1%	+13,800	New	Holders